| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 749226
[patent_doc_number] => 07022472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer'
[patent_app_type] => utility
[patent_app_number] => 09/426548
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5470
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022472.pdf
[firstpage_image] =>[orig_patent_app_number] => 09426548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/426548 | Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer | Oct 21, 1999 | Issued |
Array
(
[id] => 1272206
[patent_doc_number] => 06649158
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-18
[patent_title] => 'Methods and compositions to induce antitumor response'
[patent_app_type] => B1
[patent_app_number] => 09/416813
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9214
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649158.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416813
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416813 | Methods and compositions to induce antitumor response | Oct 12, 1999 | Issued |
Array
(
[id] => 4295372
[patent_doc_number] => 06197756
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Gene transfer of E2F-1 to inhibit vascular smooth muscle cell accumulation in vascular tissue'
[patent_app_type] => 1
[patent_app_number] => 9/416929
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 7105
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197756.pdf
[firstpage_image] =>[orig_patent_app_number] => 416929
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416929 | Gene transfer of E2F-1 to inhibit vascular smooth muscle cell accumulation in vascular tissue | Oct 12, 1999 | Issued |
Array
(
[id] => 1449687
[patent_doc_number] => 06455284
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals'
[patent_app_type] => B1
[patent_app_number] => 09/417557
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14420
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417557 | Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals | Oct 12, 1999 | Issued |
Array
(
[id] => 1532110
[patent_doc_number] => 06410314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Episomally replicating vector, its preparation and use'
[patent_app_type] => B1
[patent_app_number] => 09/412825
[patent_app_country] => US
[patent_app_date] => 1999-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6624
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09412825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/412825 | Episomally replicating vector, its preparation and use | Oct 4, 1999 | Issued |
Array
(
[id] => 4323592
[patent_doc_number] => 06329171
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => '23484, A novel human ubiquitin protease'
[patent_app_type] => 1
[patent_app_number] => 9/408865
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329171.pdf
[firstpage_image] =>[orig_patent_app_number] => 408865
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408865 | 23484, A novel human ubiquitin protease | Sep 29, 1999 | Issued |
Array
(
[id] => 1479536
[patent_doc_number] => 06451994
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => '23413, a novel human ubiquitin protease'
[patent_app_type] => B1
[patent_app_number] => 09/406045
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33417
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451994.pdf
[firstpage_image] =>[orig_patent_app_number] => 09406045
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406045 | 23413, a novel human ubiquitin protease | Sep 26, 1999 | Issued |
| 09/404895 | PLURIPOTENT EMBRYONIC-LIKE STEM CELLS, COMPOSITIONS METHODS AND USES THEREOF | Sep 23, 1999 | Abandoned |
Array
(
[id] => 4255507
[patent_doc_number] => 06207877
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding'
[patent_app_type] => 1
[patent_app_number] => 9/404208
[patent_app_country] => US
[patent_app_date] => 1999-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1934
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207877.pdf
[firstpage_image] =>[orig_patent_app_number] => 404208
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/404208 | Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding | Sep 22, 1999 | Issued |
| 09/406257 | MATERIALS AND METHODS FOR INDUCING ANGIOGENESIS AND THE REPAIR OF MAMMALIAN TISSUE | Sep 22, 1999 | Abandoned |
| 09/400967 | NUCLEIC ACIDS ENCODING VITAMIN D RESPONSE ELEMENT BINDING PROTEINS, PRODUCTS RELATED THERETO, AND METHODS OF USING SAME | Sep 21, 1999 | Abandoned |
| 09/380377 | PROCOLLAGEN ASSEMBLY | Sep 15, 1999 | Abandoned |
Array
(
[id] => 6999881
[patent_doc_number] => 20010053352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF'
[patent_app_type] => new
[patent_app_number] => 09/392822
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16348
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053352.pdf
[firstpage_image] =>[orig_patent_app_number] => 09392822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/392822 | Adenovirus vectors containing cell status-specific response elements and methods of use thereof | Sep 8, 1999 | Issued |
Array
(
[id] => 1248003
[patent_doc_number] => 06673569
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'DsbA/DsbB/DsbC/DsbD expression plasmid'
[patent_app_type] => B1
[patent_app_number] => 09/393171
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11004
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673569.pdf
[firstpage_image] =>[orig_patent_app_number] => 09393171
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/393171 | DsbA/DsbB/DsbC/DsbD expression plasmid | Sep 8, 1999 | Issued |
Array
(
[id] => 1231680
[patent_doc_number] => 06693087
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-17
[patent_title] => 'Nucleic acid molecules encoding POMP91A protein of Chlamydia'
[patent_app_type] => B1
[patent_app_number] => 09/377850
[patent_app_country] => US
[patent_app_date] => 1999-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 16880
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/693/06693087.pdf
[firstpage_image] =>[orig_patent_app_number] => 09377850
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/377850 | Nucleic acid molecules encoding POMP91A protein of Chlamydia | Aug 19, 1999 | Issued |
| 08/973589 | ESSENTIAL OLIGONUCLEOTIDES OF VERTEBRATE TELOMERASE | Aug 19, 1999 | Abandoned |
Array
(
[id] => 6611605
[patent_doc_number] => 20020064520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'TARGETED ARTIFICIAL GENE DELIVERY'
[patent_app_type] => new
[patent_app_number] => 09/377153
[patent_app_country] => US
[patent_app_date] => 1999-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8831
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064520.pdf
[firstpage_image] =>[orig_patent_app_number] => 09377153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/377153 | TARGETED ARTIFICIAL GENE DELIVERY | Aug 18, 1999 | Abandoned |
| 09/376184 | ENCAPSIDATED RECOMBINANT POLIOVIRUS NUCLELIC ACID AND METHODS OF MAKING AND USING SAME | Aug 16, 1999 | Abandoned |
Array
(
[id] => 5921880
[patent_doc_number] => 20020115202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'ADENOVIRAL VECTORS INCLUDING DNA SEQUENCES ENCODING ANGIOGENIC INHIBITORS'
[patent_app_type] => new
[patent_app_number] => 09/373938
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11382
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115202.pdf
[firstpage_image] =>[orig_patent_app_number] => 09373938
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/373938 | ADENOVIRAL VECTORS INCLUDING DNA SEQUENCES ENCODING ANGIOGENIC INHIBITORS | Aug 12, 1999 | Abandoned |
| 09/367170 | EXPRESSION OF PROTEINS FOR TREATING ASTHMA VIA LIGAND MEDIATED ACTIVATION OF THEIR ENCODING GENES | Aug 8, 1999 | Abandoned |